CPT code 90869 denotes a subsequent redetermination of the minimum intensity of electrical pulses necessary to elicit the desired brain response during therapeutic transcranial magnetic stimulation (TMS). This service is performed when ongoing management of TMS is required, commonly for patients with depression who have not responded to medications. The code captures both the measurement of motor threshold and the delivery and management of therapy adjustments, making it central to billing for follow-up TMS sessions.

Key national payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for 90869, payer coverage patterns, common billing modifiers, and related service considerations. The publication also summarizes benchmark reimbursement practices and recent policy updates that affect how follow-up TMS threshold determinations are documented and billed.

The material is intended to help billing managers, clinical program leads, and policy analysts understand the role of 90869 in ongoing TMS treatment, typical sites of service, and what to expect from major payers. Data not available in the input is identified explicitly in relevant sections.